Philip Schauer, MD

Professor of Metabolic Surgery, Director Metamor Institute, Pennington Biomedical Research Center of Louisiana State University

[MBS Digest @MBSDigest]

https://t.co/K89h6J7iPV

[MBS Digest @MBSDigest]

New on The Staple Line, the weekly audio edition of MBS Digest.

Vol. 2, No. 18: cirrhosis that regressed after bariatric surgery, surgery after GLP-1 drugs fall short, heart and kidney outcomes, and retatrutide for knee pain, each with its catch.

Link in reply.

[John David Scott MD @jdscottmd]

On this week's Staple Line, in my own voice: thirty selected patients whose cirrhosis regressed after bariatric surgery, read three ways and with no comparison group; what happens when GLP-1 drugs fall short; and retatrutide's benefits alongside its side effects. Link in reply.

[Eric Topol @EricTopol]

The obesity adverse outcome story.
BMI is a poor and misleading way to quantify obesity
When the CAD-obesity definition is used, we see the increased risk of all-cause mortality (top graphs) and lesser risk for preclinical obesity (lower graphs)
@Nature
https://t.co/mxx5ENViwz

[John David Scott MD @jdscottmd]

Paired biopsies a median 6.2 years apart: cirrhosis regressed in 33% of 30 patients with compensated MASH cirrhosis after bariatric surgery. Small and selected, no nonsurgical comparator, so an association. Article of the Week, MBS Digest Issue 18. Link in reply.

[Mediflix @MediflixTv]

What are the first steps after finding out you have lung cancer? Real doctors. Real answers. At Mediflix, you don’t have to wonder. No hallucinations. Just trusted, #DoctorApproved insights. https://t.co/sscDGbCXR9

@DrRoyHerbstYale, Medical Oncologist
@YaleCancer @SmilowCancer

[Lilly Medical US @LillyMedical]

We’re excited for Obesity Week 2026 in Washington, DC. Please visit the Lilly Medical Booth 509 – we’d love to connect with you.

Click on the video below to see registration info. It’s not too late!

[Beatlesfab4ever @Beatlesfab40]

The #Beatles performed 292 times at the Cavern Club in Mathew Street, Liverpool, between 1961 and 1963. This is their only filmed performance which took place on August 22 1962. Ringo had only joined the band one week earlier.
'Some Other Guy'
#TheBeatles

[John David Scott MD @jdscottmd]

I retired my own patient calculator this weekend.

Its replacement is ASMBS COMPASS: a free tool that shows patients which obesity treatments fit them (medications, endoscopic procedures, surgery) side by side, in plain numbers. Nothing you enter is saved.

Link in the reply.

[Neil Floch MD @NeilFlochMD]

Once you start, you should not stop GLP-1

[Lilly Medical US @LillyMedical]

Obesity Week is quickly approaching, and we are looking forward to connecting with you in Washington, DC Nov 14-17!

There Is still time to register – click on the video below to learn more.

[Ali Aminian @Ali_Aminian_MD]

This cardiovascular safety trial provides clinicians with reassuring data that treatment with survodutide, a novel glucagon receptor–GLP-1 receptor dual agonist, is not associated with increased cardiovascular risk.

[MBS Digest @MBSDigest]

https://t.co/4UvamggK9J

[MBS Digest @MBSDigest]

New from the ASMBS: COMPASS, a free patient tool comparing lifestyle programs, anti-obesity medications, endoscopic procedures and metabolic surgery.

It shows weight lost in studies for the user's own weight, and risks as "X in 100 people."

Link in the reply.

[Ali Aminian @Ali_Aminian_MD]

Bariatric Surgery Is Effective Rescue Strategy After GLP-1 Receptor Agonist Failure https://t.co/sxmnElOLO0 @AnnalsofSurgery @ASMBS #ObesityWeek #OW2026

[John David Scott MD @jdscottmd]

On this week's Staple Line, in my own voice: the Article of the Week on falling bariatric procedure volume, what bypass versus sleeve does and does not show, and a diagnostic AI study with some important caveats. https://t.co/Lx7XKVlPsF

[MBS Digest @MBSDigest]

ASMBS Weekend in Las Vegas is a chance to learn, connect and improve care. The Medicare payment cuts are a sobering backdrop. How can the specialty turn meeting momentum into a stronger voice for patient access?
https://t.co/UOc32o1A0l
https://t.co/ScPHn6jilC

[John David Scott MD @jdscottmd]

On this week's Staple Line, in my own voice: why a drop in bariatric volume can't tell us what caused it, what bypass versus sleeve does and doesn't show, and a diagnostic AI study with caveats worth hearing. Link in reply.

[Philip Schauer, MD @PSchauerMD]

Metabolic Bariatric Surgery's Safety Problem: A Messaging Opportunity, Not Just a Clinical One. The problem is the PERCEPTION of safety. National data indicates MBS safer than MOST abdominal surgery including gallbladder surgery, hernia, hysterectomy, appendectomy, hiatal hernia BUT also extends life! https://t.co/2DszfPo2pb @shanu_kothari @mattars77 @JerryDangMD @TeresaLamasters @NeilFlochMD @JaimePonceMD @metabolic_knife @Ali_Aminian_MD

[Philip Schauer, MD @PSchauerMD]

This estimate is too low. Actually, more than 200 comorbid conditions have been improved or resolved following metabolic surgery. @IfsoSecretariat @asmbs @NeilFlochMD @Jmortonmd @jdscottmd @ColleenKennedyD @Ali_Aminian_MD @metabolic_knife @mattars77 @matthew_kroh @JaimePonceMD @PaulinaSalminen @marinakurian

[IFSO @IfsoSecretariat]

Obesity is a chronic disease that can affect almost every system in the body.
METABOLIC BARIATRIC SURGERY improves more than 40 obesity-related diseases and conditions. Treating obesity means caring for the whole body.